Association Between Clincopathological Characteristics and HTERT Expression As Well As Telomere Length in Ameloblastoma

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 23

PMID 31966722

Authors

Fengyu Hao

Jie Liu

Ming Zhong

Junting Wang

Jingdong Liu

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to investigate the human telomerase reverse transcriptase (hTERT) expression and telomere length in ameloblastoma, and expolre the role of hTERT in the invasiveness and recurrence of ameloblastoma.

Methods: hTERT expression was detected by immunohistochemistry and Western blotting and telomere length by fluorescence in situ hybridization (FISH) in human ameloblastoma, normal mucosa, and oral squamous cell carcinoma (OSCC). Association between clincopathological characteristics and hTERT expression as well as telomere length in ameloblastoma was analyzed.

Results: hTERT expression in ameloblastoma was higher than that in normal oral mucosa, and the highest in OSCC (P<0.05). The hTERT positive rate and expression increased with the recurrence and malignant transformation. hTERT expression was significantly different among different types of ameloblastoma. The telomere was the shortest in OSCC and the longest in normal oral mucosa.

Conclusion: Ameloblastoma has shortened telomere, and is positive for hTERT expression which is related to the recurrence and malignancy of ameloblastoma. These findings indicate that telomerase is involved in the occurrence and development of ameloblastoma.

References

Gilijamse M, Leemans C, Winters H, Schulten E, van der Waal I . Metastasizing ameloblastoma. Int J Oral Maxillofac Surg. 2007; 36(5):462-4. DOI: 10.1016/j.ijom.2006.12.005. View

Nkenke E, Agaimy A, von Wilmowsky C, Eitner S . Mandibular reconstruction using intraoral microvascular anastomosis following removal of an ameloblastoma. J Oral Maxillofac Surg. 2013; 71(11):1983-92. DOI: 10.1016/j.joms.2013.03.027. View

Shimamoto H . [Telomerase activity in oral squamous cell carcinoma and leukoplakia]. Kokubyo Gakkai Zasshi. 2001; 68(1):125-33. DOI: 10.5357/koubyou.68.125. View

Palani J, Lakshminarayanan V, Kannan R . Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer. Indian J Dent Res. 2011; 22(2):362. DOI: 10.4103/0970-9290.84281. View

Zhong M, Zhang L, Wang J, Zhang B, Hou L . [Expression of telomerase and p53 in ameloblastoma]. Shanghai Kou Qiang Yi Xue. 2003; 12(2):127-31. View

Chen H, Yu C, Wang J, Liu B, Wang Y, Sun A . Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol. 2006; 43(2):122-9. DOI: 10.1016/j.oraloncology.2006.01.011. View

Patel M, Parekh L, Jha F, Sainger R, Patel J, Patel D . Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head Neck. 2002; 24(12):1060-7. DOI: 10.1002/hed.10169. View

Luo H, Li T . Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol. 2009; 45(8):706-11. DOI: 10.1016/j.oraloncology.2008.11.001. View

Kumamoto H, Kimi K, Ooya K . Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med. 2001; 30(10):596-602. DOI: 10.1034/j.1600-0714.2001.301004.x. View

10.

Jhamb T, Kramer J . Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeutics. Exp Mol Pathol. 2014; 97(3):345-53. DOI: 10.1016/j.yexmp.2014.09.001. View

11.

Krishna A, Kaveri H, Kumar R, Kumaraswamy K, Shylaja S, Murthy S . Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor. J Cancer Res Ther. 2012; 8(2):232-7. DOI: 10.4103/0973-1482.98976. View

12.

Raghunandan B, Sanjai K, Kumaraswamy J, Papaiah L, Pandey B, Jyothi B . Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol. 2016; 20(1):96-101. PMC: 4860945. DOI: 10.4103/0973-029X.180953. View

13.

Wu X, Amos C, Zhu Y, Zhao H, Grossman B, Shay J . Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003; 95(16):1211-8. DOI: 10.1093/jnci/djg011. View

14.

Hiyama E, Hiyama K . Clinical utility of telomerase in cancer. Oncogene. 2002; 21(4):643-9. DOI: 10.1038/sj.onc.1205070. View

15.

Antonoglou G, K Sandor G . Recurrence rates of intraosseous ameloblastomas of the jaws: a systematic review of conservative versus aggressive treatment approaches and meta-analysis of non-randomized studies. J Craniomaxillofac Surg. 2014; 43(1):149-57. DOI: 10.1016/j.jcms.2014.10.027. View

16.

Fujimoto R, Kamata N, Taki M, Yokoyama K, Tomonari M, Nagayama M . Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Oral Oncol. 2003; 39(5):445-52. DOI: 10.1016/s1368-8375(03)00003-4. View

17.

Zhong M, Li Z, Wang J, Zhang B, Hou L, Gong Y . [Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma]. Hua Xi Kou Qiang Yi Xue Za Zhi. 2005; 22(6):499-502. View

18.

Kumamoto H, Kinouchi Y, Ooya K . Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas. J Oral Pathol Med. 2001; 30(4):231-6. DOI: 10.1034/j.1600-0714.2001.300407.x. View

19.

Boscolo-Rizzo P, Rampazzo E, Perissinotto E, Piano M, Giunco S, Baboci L . Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. Oral Oncol. 2015; 51(5):500-7. DOI: 10.1016/j.oraloncology.2015.02.100. View

20.

Sathi G, Inoue M, Harada H, Rodriguez A, Tamamura R, Tsujigiwa H . Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma. Oral Oncol. 2009; 45(10):856-60. DOI: 10.1016/j.oraloncology.2009.02.001. View